肉瘤样肝内胆管细胞癌2例误诊分析
Misdiagnosis Analysis of 2 Cases of Sarcomatoid Intrahepatic Cholangiocarcinoma
DOI: 10.12677/MD.2021.111002, PDF,    科研立项经费支持
作者: 刘智贤:武汉科技大学临床医学院,湖北 武汉;洪 凡*, 高银华, 刘汉忠*:武汉科技大学附属孝感医院(湖北省孝感市中心医院),湖北 孝感
关键词: 肉瘤样肝内胆管细胞癌免疫组化诊断鉴别诊断Sarcomatoid Intrahepatic Cholangiocarcinoma Immunohistochemical Diagnosis Distinguish
摘要: 目的:对2例肉瘤样肝内胆管细胞癌病例误诊进行分析,提高对肉瘤样肝内胆管细胞癌的病理诊断能力。方法:对本院收治的2例肉瘤样肝内胆管细胞癌误诊为上皮样血管肉瘤,进行形态学与免疫组化进行分析,探讨误诊原因。结果:肉瘤样肝内胆管细胞癌在形态学与免疫组织化学上具有上皮、间叶双向分化特点,与上皮样血管肉瘤在组织学、免疫组化有共性也不同。结论:肉瘤样肝内胆管细胞癌病理诊断容易误诊,在诊断方面需要形态学与免疫组织化学的结合,同时进行必要的网状纤维染色等进一步鉴别。
Abstract: Objective: Misdiagnosis analysis was performed on 2 cases of sarcomatoid intrahepatic cholangio-carcinoma to improve the pathological diagnosis of sarcoma-like intrahepatic bile duct cell carci-noma. Methods: Two cases of sarcomatoid intrahepatic cholangiocarcinoma admitted to our hospital were analyzed by pathological diagnosis, morphology and immunohistochemistry, and meanwhile, the differential diagnosis was analyzed with epithelioid angiosarcoma. Results: Sarcomatoid intra-hepatic cholangiocarcinoma has some morphological and immunohistochemical characteristics, which are characterized by bidirectional differentiation of epithelial mesenchymal cells, and are different from epithelioid angiosarcoma in histology and immunohistochemistry. Conclusion: The diagnosis of sarcomatoid intrahepatic cholangiocarcinoma requires the combination of morphology and immunohistochemistry, and further differentiation of epithelioid angiosarcoma in morphology, immunohistochemistry and reticular fiber staining.
文章引用:刘智贤, 洪凡, 高银华, 刘汉忠. 肉瘤样肝内胆管细胞癌2例误诊分析[J]. 医学诊断, 2021, 11(1): 8-12. https://doi.org/10.12677/MD.2021.111002

参考文献

[1] Kim, D.K., Kim, B.R., Jeong, J.S., et al. (2019) Analysis of Intrahepatic Sarcomatoid Cholangiocarcinoma: Experience from 11 Cases within 17 Years. World Journal of Gastroenterology, 25, 608-621. [Google Scholar] [CrossRef] [PubMed]
[2] Aishima, S., Kuroda, Y., Asayama, Y., et al. (2006) Prognostic Impact of Cholangiocellular and Sarcomatous Components in Combined Hepatocellular and Cholangiocarcinoma. Human Pathology, 37, 283-291. [Google Scholar] [CrossRef] [PubMed]
[3] Watanabe, G., Uchinami, H., Yoshioka, M., et al. (2014) Prognosis Analysis of Sarcomatous Intrahepatic Cholangiocarcinoma from a Review of the Literature. International Journal of Clinical Oncology, 19, 490-496. [Google Scholar] [CrossRef] [PubMed]
[4] Tsou, Y.K., Wu, R.C., Hung, C.F., et al. (2008) Intrahepatic Sarcomatoid Cholangiocarcinoma: Clinical Analysis of Seven Cases during a 15-Year Period. Chang Gung Med J, 31, 599-605.
[5] Kaibori, M., Kawaguchi, Y., Yokoigawa, N., et al. (2003) Intrahepatic Sarcomatoid Cholangiocarcinoma. Journal of Gastroenterology, 38, 1097-1101. [Google Scholar] [CrossRef] [PubMed]
[6] Malhotra, S., Wood, J., Mansy, T., et al. (2010) Intrahepatic Sarcomatoid Cholangiocarcinoma. Journal of Oncology, 2010, Article ID: 701476. [Google Scholar] [CrossRef] [PubMed]
[7] 张欣, 周成, 周恺乾, 等. 肉瘤样肝细胞癌中MET基因扩增与预后的相关性分析[J]. 中国癌症杂志, 2020, 30(9): 641-649.
[8] 郑杰主, 译. 外科病理学: 第10版[M]. 北京: 北京大学医学出版社, 2014.
[9] 马逸群, 王家平, 李天祎, 等. 肉瘤样肝细胞癌CT与MRI表现及病理分析[J]. 医学影像学杂志, 2020, 30(6): 1005-1007.